Whye-kei Lye BSc, PhD

Dr. Lye is the Director of Business Development (Future Health Care) at the NTUitive Pte Ltd, the technology transfer arm of the Nanyang Technological University in Singapore. He is also the CEO of SysteMED Private Limited, a medical technology incubator wholly owned by NTU, and was a founder-partner at Nairos LLC, a medtech consulting firm. Prior to Nairos, Dr. Lye was CTO-founder of Setagon, Inc., a startup which developed several proprietary stent technologies, including a metallic nanoporous surface modification for medical devices such as coronary stents.

Setagon obtained over US$5.5 million in venture financing and was acquired by Medtronic. Whye-Kei is the primary inventor of the acquired technology and has over 28 patents/patent applications. His technical experience includes work in the fields of nanoscale materials, micro-electromechanical systems, and biological nanosystems. He has a B.Sc. (Honors) from the California Institute of Technology, and a PhD from Yale University.